AKT1 and breast carcinoma: Taken together, we support that adipocytes in the tumor microenvironment induce breast cancer progression through activating the PI3K-AKT-mTOR signaling pathway, suggesting inhibition of dual target such as PI3K and mTOR as a potentially good option for developing a novel targeted therapy for breast cancer.